These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 17009092)
41. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors. Rella M; Rushworth CA; Guy JL; Turner AJ; Langer T; Jackson RM J Chem Inf Model; 2006; 46(2):708-16. PubMed ID: 16563001 [TBL] [Abstract][Full Text] [Related]
42. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps. Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304 [TBL] [Abstract][Full Text] [Related]
43. Virtual screening and rational drug design method using structure generation system based on 3D-QSAR and docking. Chen HF; Dong XC; Zen BS; Gao K; Yuan SG; Panaye A; Doucet JP; Fan BT SAR QSAR Environ Res; 2003 Aug; 14(4):251-64. PubMed ID: 14506869 [TBL] [Abstract][Full Text] [Related]
44. Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling. Vuorinen A; Schuster D Methods; 2015 Jan; 71():113-34. PubMed ID: 25461773 [TBL] [Abstract][Full Text] [Related]
45. Highly specific and sensitive pharmacophore model for identifying CXCR4 antagonists. Comparison with docking and shape-matching virtual screening performance. Karaboga AS; Planesas JM; Petronin F; Teixidó J; Souchet M; Pérez-Nueno VI J Chem Inf Model; 2013 May; 53(5):1043-56. PubMed ID: 23577723 [TBL] [Abstract][Full Text] [Related]
46. DiSCuS: an open platform for (not only) virtual screening results management. Wójcikowski M; Zielenkiewicz P; Siedlecki P J Chem Inf Model; 2014 Jan; 54(1):347-54. PubMed ID: 24364790 [TBL] [Abstract][Full Text] [Related]
47. 3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design. Ye Y; Liao Q; Wei J; Gao Q Neurochem Int; 2010 Jan; 56(1):107-17. PubMed ID: 19782115 [TBL] [Abstract][Full Text] [Related]
48. Development and evaluation of an integrated virtual screening strategy by combining molecular docking and pharmacophore searching based on multiple protein structures. Tian S; Sun H; Li Y; Pan P; Li D; Hou T J Chem Inf Model; 2013 Oct; 53(10):2743-56. PubMed ID: 24010823 [TBL] [Abstract][Full Text] [Related]
49. Pharmacophore modeling, docking, and principal component analysis based clustering: combined computer-assisted approaches to identify new inhibitors of the human rhinovirus coat protein. Steindl TM; Crump CE; Hayden FG; Langer T J Med Chem; 2005 Oct; 48(20):6250-60. PubMed ID: 16190752 [TBL] [Abstract][Full Text] [Related]
50. A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication. Bender A; Glen RC J Chem Inf Model; 2005; 45(5):1369-75. PubMed ID: 16180913 [TBL] [Abstract][Full Text] [Related]
51. Multiple-step virtual screening using VSM-G: overview and validation of fast geometrical matching enrichment. Beautrait A; Leroux V; Chavent M; Ghemtio L; Devignes MD; Smaïl-Tabbone M; Cai W; Shao X; Moreau G; Bladon P; Yao J; Maigret B J Mol Model; 2008 Feb; 14(2):135-48. PubMed ID: 18172702 [TBL] [Abstract][Full Text] [Related]
52. Enrichment assessment of multiple virtual screening strategies for Toll-like receptor 8 agonists based on a maximal unbiased benchmarking data set. Pei F; Jin H; Zhou X; Xia J; Sun L; Liu Z; Zhang L Chem Biol Drug Des; 2015 Nov; 86(5):1226-41. PubMed ID: 26017460 [TBL] [Abstract][Full Text] [Related]
53. Consideration of molecular weight during compound selection in virtual target-based database screening. Pan Y; Huang N; Cho S; MacKerell AD J Chem Inf Comput Sci; 2003; 43(1):267-72. PubMed ID: 12546562 [TBL] [Abstract][Full Text] [Related]
54. Pharmacophore modeling and hybrid virtual screening for the discovery of novel IκB kinase 2 (IKK2) inhibitors. Xie HZ; Liu LY; Ren JX; Zhou JP; Zheng RL; Li LL; Yang SY J Biomol Struct Dyn; 2011 Aug; 29(1):165-79. PubMed ID: 21696232 [TBL] [Abstract][Full Text] [Related]
55. Exploration of Mycobacterium tuberculosis structural proteome: An in-silico approach. Lone MY; Kumar SP; Athar M; Jha PC J Theor Biol; 2018 Feb; 439():14-23. PubMed ID: 29197513 [TBL] [Abstract][Full Text] [Related]
56. Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents. Klimenko K; Lyakhov S; Shibinskaya M; Karpenko A; Marcou G; Horvath D; Zenkova M; Goncharova E; Amirkhanov R; Krysko A; Andronati S; Levandovskiy I; Polishchuk P; Kuz'min V; Varnek A Bioorg Med Chem Lett; 2017 Aug; 27(16):3915-3919. PubMed ID: 28666733 [TBL] [Abstract][Full Text] [Related]
57. Alpha sphere filter method: Application of pseudomolecular descriptors in virtual screening of 2D chemical structures. Muta H; Hirayama N J Comput Chem; 2010 Aug; 31(11):2225-32. PubMed ID: 20340104 [TBL] [Abstract][Full Text] [Related]
58. Identification of potential dual agonists of FXR and TGR5 using e-pharmacophore based virtual screening. Sindhu T; Srinivasan P Mol Biosyst; 2015 May; 11(5):1305-18. PubMed ID: 25787676 [TBL] [Abstract][Full Text] [Related]
59. Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches. Vucicevic J; Nikolic K; Mitchell JBO Curr Med Chem; 2019; 26(21):3874-3889. PubMed ID: 28707592 [TBL] [Abstract][Full Text] [Related]
60. Discovery of potent inhibitors targeting Vibrio harveyi LuxR through shape and e-pharmacophore based virtual screening and its biological evaluation. Rajamanikandan S; Jeyakanthan J; Srinivasan P Microb Pathog; 2017 Feb; 103():40-56. PubMed ID: 27939874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]